PARP inhibitors and stratified treatment of prostate cancer

被引：5
|
作者：
Lavery, Anita [1 ]
Gilson, Clare [2 ]
Chowdhury, Simon [3 ]
机构：
[1] Guys Hosp, Med Oncol, London, England
[2] UCL, MRC Clin Trials Unit, London, England
[3] Guys Hosp, London, England
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2016年 / 16卷 / 12期
关键词：
Biomarker; BRCA1/2; mutation; PARP inhibitor; prostate cancer; stratification; targeted therapy; HOMOLOGOUS RECOMBINATION; INCREASED SURVIVAL; REPAIR DEFECTS; RESISTANCE; BIOMARKERS; BRCA2;
D O I：
10.1080/14737140.2016.1243474
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1213 / 1215
页数：3
相关论文
共 50 条
  • [1] PARP inhibitors for prostate cancer
    Longoria, Ossian
    Beije, Nick
    de Bono, Johann S.
    [J]. SEMINARS IN ONCOLOGY, 2024, 51 (1-2) : 25 - 35
  • [2] PARP Inhibitors in Prostate Cancer
    Geethakumari, Praveen Ramakrishnan
    Schiewer, Matthew J.
    Knudsen, Karen E.
    Kelly, Wm. Kevin
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (06)
  • [3] PARP Inhibitors in Prostate Cancer
    Praveen Ramakrishnan Geethakumari
    Matthew J. Schiewer
    Karen E. Knudsen
    Wm. Kevin Kelly
    [J]. Current Treatment Options in Oncology, 2017, 18
  • [4] PARP Inhibitors in Prostate Cancer
    Grewal, Kabir
    Grewal, Kayanaat
    Tabbara, Imad A.
    [J]. ANTICANCER RESEARCH, 2021, 41 (02) : 551 - 556
  • [5] Advances in PARP Inhibitors for Prostate Cancer
    Tisseverasinghe, Steven
    Bahoric, Boris
    Anidjar, Maurice
    Probst, Stephan
    Niazi, Tamim
    [J]. CANCERS, 2023, 15 (06)
  • [6] PARP inhibitors in metastatic prostate cancer
    Taylor, Amy K.
    Kosoff, David
    Emamekhoo, Hamid
    Lang, Joshua M.
    Kyriakopoulos, Christos E.
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] Structurally unique PARP-1 inhibitors for the treatment of prostate cancer
    Divan, Ali
    Sibi, Mukund P.
    Tulin, Alexei
    [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2020, 8 (02):
  • [8] PARP inhibitors in cancer treatment
    Calvert, H.
    Plummer, E. R.
    Curtin, N. J.
    Edmondson, R.
    Drew, Y.
    [J]. EJC SUPPLEMENTS, 2008, 6 (12): : 80 - 80
  • [9] Development of PARP inhibitors in advanced prostate cancer
    Bourlon, Maria Teresa
    Valdez, Paola
    Castro, Elena
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [10] Prostate cancer and PARP inhibitors: progress and challenges
    Teyssonneau, Diego
    Margot, Henri
    Cabart, Mathilde
    Anonnay, Mylene
    Sargos, Paul
    Vuong, Nam-Son
    Soubeyran, Isabelle
    Sevenet, Nicolas
    Roubaud, Guilhem
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
12345